News

Diabetic CHD Patients Need Lipid Lowering, Too


 

There were no differences in treatment-related side effects between the 10-mg and 80-mg diabetic groups.

Treatment-related myalgia occurred in 3.6% of the 10-mg group and 2.4% of those taking 80 mg, while persistent liver-enzyme elevations three times the upper limit of normal occurred in 0.4% vs. 0.8%, respectively. No cases of rhabdomyolysis occurred in any patient throughout the 5 study years.

Pages

Recommended Reading

Internists' Effort Seeks to Improve Outcomes for Diabetes Patients
MDedge Family Medicine
Low Calcium Score May Mask CHD in Diabetics : Even a score of 0 poses a higher atherosclerotic burden for a diabetic than a nondiabetic patient.
MDedge Family Medicine
Diet + Exercise Beats Exercise Alone for Metabolic Syndrome
MDedge Family Medicine
EHRs Do Not Improve Adherence To Diabetes Guidelines in Study
MDedge Family Medicine
Clinical Capsules
MDedge Family Medicine
Monotherapy Option for Type 2 Diabetes Patients : Muraglitazar effectively lowered hemoglobin A1c and triglycerides while raising HDL cholesterol levels.
MDedge Family Medicine
Little Data About Androgens In Postmenopausal Women
MDedge Family Medicine
Moderate Exercise Helps Insulin Sensitivity in PCOS
MDedge Family Medicine
Women's Weight Gain Higher on Thiazolidinedione
MDedge Family Medicine
Subclinical Hypothyroidism Linked to Heart Failure
MDedge Family Medicine